Gaurav Kumar1, Mudassir Farooqui1, Chinthalapally V Rao1. 1. Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology, The University of Oklahoma Health Sciences Center, and VA Medical Center, Oklahoma City, United States.
Abstract
PURPOSE OF REVIEW: This article provides a brief overview of cancer-preventive phytochemicals specifically targeting pancreatic cancer (PC) stem cells for prevention and treatment. RECENT FINDINGS: Cancer stem cells (CSCs) represent a small proportion of the total cells of a given tumor, and contribute to tumor growth, recurrence, metastasis, and treatment resistance. Many intertwined pathways, including hedgehog, Wnt Signaling, and NOTCH, have been shown to play a role in the formation of CSCs. Recently, numerous chemopreventive agents, such as genistein, (-)-epigallocatechin-3-gallate (EGCG), sulforaphane, curcumin, resveratrol, and quercetin, have been shown to target CSCs mediated through the inhibition of multiple signalling pathways, to avoid toxicity and the side effects of chemical compounds. SUMMARY: A growing body of research suggests that CSCs are the drivers in treatment resistance, cancer recurrence, and metastasis, in addition to tumor initiation and heterogeneity. Patient survival depends on these CSCs, which are one cause of tumor recurrence after surgery and chemotherapy. Therefore, target selection; an improved understanding of CSC biology, the genetic and molecular profiles of CSCs, and their key signaling pathways, and; appropriate clinical trials endpoints that are designed to target CSCs will help in the development of drugs that will specifically target this small population of stem cells.
PURPOSE OF REVIEW: This article provides a brief overview of cancer-preventive phytochemicals specifically targeting pancreatic cancer (PC) stem cells for prevention and treatment. RECENT FINDINGS: Cancer stem cells (CSCs) represent a small proportion of the total cells of a given tumor, and contribute to tumor growth, recurrence, metastasis, and treatment resistance. Many intertwined pathways, including hedgehog, Wnt Signaling, and NOTCH, have been shown to play a role in the formation of CSCs. Recently, numerous chemopreventive agents, such as genistein, (-)-epigallocatechin-3-gallate (EGCG), sulforaphane, curcumin, resveratrol, and quercetin, have been shown to target CSCs mediated through the inhibition of multiple signalling pathways, to avoid toxicity and the side effects of chemical compounds. SUMMARY: A growing body of research suggests that CSCs are the drivers in treatment resistance, cancer recurrence, and metastasis, in addition to tumor initiation and heterogeneity. Patient survival depends on these CSCs, which are one cause of tumor recurrence after surgery and chemotherapy. Therefore, target selection; an improved understanding of CSC biology, the genetic and molecular profiles of CSCs, and their key signaling pathways, and; appropriate clinical trials endpoints that are designed to target CSCs will help in the development of drugs that will specifically target this small population of stem cells.
Entities:
Keywords:
cancer stem cells; pancreatic cancer; phytochemicals; polyphenols
Authors: Sanjeev Banerjee; Yuxiang Zhang; Shadan Ali; Mohammad Bhuiyan; Zhiwei Wang; Paul J Chiao; Philip A Philip; James Abbruzzese; Fazlul H Sarkar Journal: Cancer Res Date: 2005-10-01 Impact factor: 12.701
Authors: D Neil Watkins; David M Berman; Scott G Burkholder; Baolin Wang; Philip A Beachy; Stephen B Baylin Journal: Nature Date: 2003-03-05 Impact factor: 49.962
Authors: A Apelqvist; H Li; L Sommer; P Beatus; D J Anderson; T Honjo; M Hrabe de Angelis; U Lendahl; H Edlund Journal: Nature Date: 1999-08-26 Impact factor: 49.962
Authors: Yoshiharu Miyamoto; Anirban Maitra; Bidyut Ghosh; Ulrich Zechner; Pedram Argani; Christine A Iacobuzio-Donahue; Virote Sriuranpong; Tatsuya Iso; Ingrid M Meszoely; Michael S Wolfe; Ralph H Hruban; Douglas W Ball; Roland M Schmid; Steven D Leach Journal: Cancer Cell Date: 2003-06 Impact factor: 31.743
Authors: Emmanuelle Passegué; Catriona H M Jamieson; Laurie E Ailles; Irving L Weissman Journal: Proc Natl Acad Sci U S A Date: 2003-09-22 Impact factor: 11.205
Authors: David M Berman; Sunil S Karhadkar; Anirban Maitra; Rocio Montes De Oca; Meg R Gerstenblith; Kimberly Briggs; Antony R Parker; Yutaka Shimada; James R Eshleman; D Neil Watkins; Philip A Beachy Journal: Nature Date: 2003-09-14 Impact factor: 49.962
Authors: D T Silverman; M Schiffman; J Everhart; A Goldstein; K D Lillemoe; G M Swanson; A G Schwartz; L M Brown; R S Greenberg; J B Schoenberg; L M Pottern; R N Hoover; J F Fraumeni Journal: Br J Cancer Date: 1999-08 Impact factor: 7.640
Authors: Marta Gómez de Cedrón; Lamia Mouhid; Elena García-Carrascosa; Tiziana Fornari; Guillermo Reglero; Ana Ramírez de Molina Journal: Front Bioeng Biotechnol Date: 2020-01-24
Authors: Alena Liskova; Peter Kubatka; Marek Samec; Pavol Zubor; Milos Mlyncek; Tibor Bielik; Samson Mathews Samuel; Anthony Zulli; Taeg Kyu Kwon; Dietrich Büsselberg Journal: Molecules Date: 2019-03-04 Impact factor: 4.411